| RS1567612647 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567613569 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567613595 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567613604 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567613616 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567613630 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567613669 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS1567613682 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567614073 |
PIGS
|
Health Risk |
Pathogenic |
Glycosylphosphatidylinositol biosynthesis defect 18, Glycosylphosphatidylinositol biosynthesis defect 18 |
| RS1567614360 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS1567614448 |
ANKRD11
|
Health Risk |
Likely pathogenic |
— |
| RS1567615766 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567615852 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567615872 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567615902 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567615941 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567616135 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1567616570 |
PIGS
|
Health Risk |
Pathogenic |
Glycosylphosphatidylinositol biosynthesis defect 18, Glycosylphosphatidylinositol biosynthesis defect 18 |
| RS1567616649 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis |
| RS1567616704 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567616894 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567616928 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567616975 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567617045 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567617129 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567617158 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567617371 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567617536 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567617669 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567617727 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567617849 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567617877 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567618250 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567618264 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1567618413 |
PIGS
|
Health Risk |
Likely pathogenic |
Glycosylphosphatidylinositol biosynthesis defect 18, Glycosylphosphatidylinositol biosynthesis defect 18 |
| RS1567618790 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1567618907 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1567619102 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567619134 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567620374 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS1567620403 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567620939 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Nonsyndromic genetic hearing loss |
| RS1567621034 |
PMFBP1
|
Health Risk |
Pathogenic |
Spermatogenic failure 31, Spermatogenic failure 31 |
| RS1567621042 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1567623176 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1567623439 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567623480 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567623508 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567624190 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1567625065 |
WWOX
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS1567625163 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567626023 |
CARMIL2
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to CARMIL2 deficiency, Severe combined immunodeficiency due to CARMIL2 deficiency |
| RS1567626632 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567626919 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567626945 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567627138 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567627210 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567627217 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567627268 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567627282 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567627286 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567627709 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567627751 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567627755 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567628294 |
CARMIL2
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to CARMIL2 deficiency, Severe combined immunodeficiency due to CARMIL2 deficiency |
| RS1567628757 |
CARMIL2
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to CARMIL2 deficiency, Severe combined immunodeficiency due to CARMIL2 deficiency |
| RS1567628967 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1567629943 |
CARMIL2
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to CARMIL2 deficiency, Severe combined immunodeficiency due to CARMIL2 deficiency |
| RS1567629968 |
CARMIL2
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined immunodeficiency, Chronic colitis |
| RS1567632441 |
FA2H
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 35, Hereditary spastic paraplegia 35 |
| RS1567632829 |
CARMIL2
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to CARMIL2 deficiency, Severe combined immunodeficiency due to CARMIL2 deficiency |
| RS1567632864 |
CARMIL2
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to CARMIL2 deficiency, Severe combined immunodeficiency due to CARMIL2 deficiency |
| RS1567633766 |
FA2H
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 35, Hereditary spastic paraplegia 35 |
| RS1567635573 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1567635867 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1567635954 |
CHRNE
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1567636493 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4C, Congenital myasthenic syndrome 4C |
| RS1567636622 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4B, Congenital myasthenic syndrome 4A |
| RS1567636915 |
MLYCD
|
Health Risk |
Pathogenic |
Deficiency of malonyl-CoA decarboxylase, Deficiency of malonyl-CoA decarboxylase |
| RS1567637144 |
AIPL1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS1567637467 |
AIPL1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS1567638401 |
CHRNE
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4C |
| RS1567638550 |
CHRNE
|
Health Risk |
Pathogenic |
— |
| RS1567638676 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1567638693 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1567639631 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1567639913 |
CHRNE
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1567641234 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Hearing loss |
| RS1567642367 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1567644030 |
CERS3
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 9, Autosomal recessive congenital ichthyosis 9 |
| RS1567645786 |
FANCA
|
Health Risk |
Likely pathogenic |
— |
| RS1567648703 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1567649945 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, MYO15A-related disorder |
| RS1567650859 |
SLC25A11
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 6, Pheochromocytoma/paraganglioma syndrome 6 |
| RS1567650874 |
SLC25A11
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 6, Pheochromocytoma/paraganglioma syndrome 6 |
| RS1567650971 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS1567651815 |
SLC25A11
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 6, Pheochromocytoma/paraganglioma syndrome 6 |
| RS1567652792 |
MYO15A
|
Health Risk |
Likely pathogenic |
— |
| RS1567657684 |
ADAMTS17
|
Health Risk |
Pathogenic |
— |
| RS1567658710 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |